Sports Medicine and Anti-Doping Service Republican Centre
Yerevan, Armenia
NCT Number: NCT03947554
This study evaluates the effects of a specific herbal preparation of Panax ginseng in preventing symptoms of stress in healthy individuals.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 1 / Phase 2
Yerevan, Armenia
HRG80 is an herbal preparation of Panax ginseng with a higher concentration of bioavailable ginsenosides than typical Korean ginseng. This study will test whether HRG80 is effective at preventing symptoms of stress, such as fatigue, impaired memory, difficulty in concentration, attention deficit, restlessness, and irritation related to daily work situations of healthy individuals in comparison to placebo and a standard Pananx ginseng with a lower concentration of ginsenosides.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Panax ginseng containing 63.4 mg ginsenosides
Panax ginseng containing 19.6 mg ginsenosides
800 mg excipient
Time frame: Two weeks
The Perceived Stress Scale is a psychological instrument for measuring the perception of stress by an individual. Scores from 0-13 indicate low stress, 14-26 is considered moderate stress, and scores from 27-40 indicate high perceived stress. The primary outcome is the change in the baseline PSS score for HRG80 versus standard Panax ginseng and placebo.
EuroPharma, Inc.
Industry
Study of the Efficacy of Panax Ginseng Herbal Preparation HRG80 for Prevention and Mitigation of the Symptoms of Stress in Healthy Subjects
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05433662
Behavior, Behavioral Symptoms
Tuscaloosa, Alabama, United States
View Trial DetailsNCT07702682
Behavior, Behavioral Symptoms
Elâzığ, Turkey (Türkiye)
View Trial DetailsNCT04680611
Adjustment, Adjustment, Emotional
Aberdeen, Grampian, United Kingdom
View Trial DetailsNCT07690553
Behavior, Behavioral Symptoms
Wuhan, Hubei, China
View Trial Details